hearing loss
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
Premium
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss
Qualifying children will have free access to Invitae's Comprehensive Deafness Panel, which assesses multiple genes linked to syndromic and non-syndromic deafness.
UK Newborn Trial to Assess PCR Test for Antibiotic-Induced Hearing Loss
The pharmacogenetic test, which runs on a platform from British company Genedrive, will be tested in two neonatal intensive care units in Manchester and Liverpool.
The test is the cornerstone of a study involving roughly a thousand patients from two British neonatal centers that is set to commence this fall.
Last year, the firm saw 21 percent growth in reproductive health, 56 percent growth in oncology, and 49 percent growth in infectious disease testing.
Apr 11, 2018